LAZARD ASSET MANAGEMENT LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 237 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$327
+147.7%
11,905
+170.8%
0.00%
Q2 2023$132
+112.9%
4,397
+151.5%
0.00%
Q4 2022$62
-99.9%
1,7480.0%0.00%
Q3 2022$59,000
-41.6%
1,748
-50.0%
0.00%
Q2 2022$101,000
+55.4%
3,498
+71.6%
0.00%
Q1 2022$65,000
+10.2%
2,038
+0.7%
0.00%
Q4 2021$59,000
+28.3%
2,024
+15.7%
0.00%
Q3 2021$46,000
-22.0%
1,750
-9.3%
0.00%
Q2 2021$59,000
+18.0%
1,9300.0%0.00%
Q1 2021$50,000
-2.0%
1,930
-21.6%
0.00%
Q3 2020$51,000
-5.6%
2,461
+7.7%
0.00%
Q4 2019$54,000
+350.0%
2,284
+393.3%
0.00%
Q3 2019$12,000
-99.4%
463
-98.6%
0.00%
-100.0%
Q2 2018$2,013,000
+30.6%
33,6500.0%0.00%0.0%
Q1 2018$1,541,000
+10.1%
33,650
-4.3%
0.00%
+50.0%
Q4 2017$1,400,000
-34.8%
35,150
-34.5%
0.00%
-50.0%
Q3 2017$2,146,000
-22.0%
53,650
-16.0%
0.00%
-20.0%
Q2 2017$2,751,000
+33.1%
63,850
-3.3%
0.01%
+25.0%
Q1 2017$2,067,000
-42.9%
66,050
-53.9%
0.00%
-42.9%
Q4 2016$3,618,000
+2.1%
143,3000.0%0.01%0.0%
Q3 2016$3,543,000
+21.4%
143,3000.0%0.01%
+16.7%
Q2 2016$2,919,000143,3000.01%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders